RSNA

RAPID + TCT Sets Strategic Direction, Releases Schedule for 2024-26 Events

Retrieved on: 
Wednesday, March 20, 2024

In 2026, RAPID + TCT will take place April 14-16 in Boston for the first time at the Boston Convention & Exhibition Center.

Key Points: 
  • In 2026, RAPID + TCT will take place April 14-16 in Boston for the first time at the Boston Convention & Exhibition Center.
  • “It’s important that we signpost to the industry what our plans are,” said Duncan Wood, Rapid News Group CEO.
  • For more details about this year’s edition of RAPID + TCT, visit rapid3devent.com .
  • Additional details about the 2025 and 2026 editions of RAPID + TCT, including information for exhibitors, will be available soon.

RSNA: Early Coronary Disease, Impaired Heart Function Found in Asymptomatic People with HIV

Retrieved on: 
Thursday, April 4, 2024

OAK BROOK, Ill., April 4, 2024 /PRNewswire-PRWeb/ -- A new study found increased coronary vessel wall thickness that was significantly associated with impaired diastolic function in asymptomatic, middle-aged individuals living with HIV. The study was published today in Radiology: Cardiothoracic Imaging, a journal of the Radiological Society of North America (RSNA).

Key Points: 
  • A new study found increased coronary vessel wall thickness that was significantly associated with impaired diastolic function in asymptomatic, middle-aged individuals living with HIV.
  • The ability to detect early coronary artery disease in persons living with HIV and potentially prevent detrimental effects on the heart muscle is important.
  • This research shows the impact of HIV on developing subtle subclinical coronary artery disease and its effects on heart function.
  • "This research shows the impact of HIV on developing subtle subclinical coronary artery disease and its effects on heart function."

Vieworks Unveils Cutting-Edge X-ray Imaging Solutions at ECR 2024

Retrieved on: 
Tuesday, February 27, 2024

ANYANG, South Korea, Feb. 27, 2024 /PRNewswire/ -- Vieworks, a leading provider of medical and industrial X-ray imaging solutions, is gearing up to showcase its innovative lineup at the European Congress of Radiology (ECR) 2024, scheduled from February 28 to March 3 in Vienna, Austria.

Key Points: 
  • ANYANG, South Korea, Feb. 27, 2024 /PRNewswire/ -- Vieworks, a leading provider of medical and industrial X-ray imaging solutions, is gearing up to showcase its innovative lineup at the European Congress of Radiology (ECR) 2024, scheduled from February 28 to March 3 in Vienna, Austria.
  • At the exhibition, Vieworks will unveil a total of 19 products, featuring 15 static and dynamic flat panel detectors accompanied by dedicated image acquisition software.
  • Particularly noteworthy will be the introduction of the enhanced VXvue software integrated with AI diagnostic support solutions.
  • Developed in-house by Vieworks, VXvue is a user-centric image processing software designed to post-process clinical images acquired through X-ray detectors.

Vieworks Unveils Cutting-Edge X-ray Imaging Solutions at ECR 2024

Retrieved on: 
Tuesday, February 27, 2024

ANYANG, South Korea, Feb. 27, 2024 /PRNewswire/ -- Vieworks, a leading provider of medical and industrial X-ray imaging solutions, is gearing up to showcase its innovative lineup at the European Congress of Radiology (ECR) 2024, scheduled from February 28 to March 3 in Vienna, Austria.

Key Points: 
  • ANYANG, South Korea, Feb. 27, 2024 /PRNewswire/ -- Vieworks, a leading provider of medical and industrial X-ray imaging solutions, is gearing up to showcase its innovative lineup at the European Congress of Radiology (ECR) 2024, scheduled from February 28 to March 3 in Vienna, Austria.
  • At the exhibition, Vieworks will unveil a total of 19 products, featuring 15 static and dynamic flat panel detectors accompanied by dedicated image acquisition software.
  • Particularly noteworthy will be the introduction of the enhanced VXvue software integrated with AI diagnostic support solutions.
  • Developed in-house by Vieworks, VXvue is a user-centric image processing software designed to post-process clinical images acquired through X-ray detectors.

RSNA: Researchers Look at Environmental Impacts of AI Tools

Retrieved on: 
Tuesday, February 27, 2024

OAK BROOK, Ill., Feb. 27, 2024 /PRNewswire-PRWeb/ -- As artificial intelligence (AI) is increasingly used in radiology, researchers caution that it's essential to consider the environmental impact of AI tools, according to a focus article published today in Radiology, a journal of the Radiological Society of North America (RSNA).

Key Points: 
  • "The development and deployment of AI models consume large amounts of energy, and the data storage needs in medical imaging and AI are growing exponentially."
  • Dr. Hanneman and a team of researchers looked at the benefits and downsides of incorporating AI tools into radiology.
  • However, the energy required to develop AI tools and store the associated data significantly contributes to GHG.
  • To decrease GHG emissions from data storage and the AI model development process, the researchers also offered other suggestions.

RSNA: Annual Breast Cancer Screening Beginning at 40 Saves Lives

Retrieved on: 
Tuesday, February 20, 2024

OAK BROOK, Ill., Feb. 20, 2024 /PRNewswire-PRWeb/ -- Annual breast cancer screening beginning at age 40 and continuing to at least age 79 results in the highest reduction in mortality with minimal risks, according to a new study published today in Radiology, a journal of the Radiological Society of North America (RSNA).

Key Points: 
  • Despite research demonstrating that consistent participation in screening mammography can reduce breast cancer deaths by 40%, only 50% or less of eligible women actually participate in annual screening.
  • The American College of Radiology, the Society of Breast Imaging and the National Comprehensive Cancer Network recommend annual screening for women at average risk for breast cancer beginning at age 40 and continuing as long as the woman is in good health.
  • In the study, Dr. Monticciolo and colleagues performed a secondary analysis of Cancer Intervention and Surveillance Modeling Network (CISNET) 2023 median estimates of breast cancer screening outcomes.
  • The researchers compared the benefits of screening, including mortality reduction, life years gained, breast cancer deaths averted, and its risks—including benign, or unnecessary, biopsies and recall rates—for four different scenarios: biennial screening of women 50-74 (the longstanding USPSTF recommendation), biennial screening of women 40-74 (the task force's new draft recommendation), annual screening 40-74, and annual screening 40-79.

VinBrain to Launch AI-centric Solutions to Save Lives and Advance Precision Care at RSNA 2023

Retrieved on: 
Monday, December 4, 2023

Unveiling two impactful AI-centric solutions during the event - DrAid Enterprise Data Solution: Centralization, Transformation, Intelligence; and DrAid Oncology Diagnosis and Treatment, VinBrain takes major steps forward in innovation, aiming to save more lives and advance precision care for everyone.

Key Points: 
  • Unveiling two impactful AI-centric solutions during the event - DrAid Enterprise Data Solution: Centralization, Transformation, Intelligence; and DrAid Oncology Diagnosis and Treatment, VinBrain takes major steps forward in innovation, aiming to save more lives and advance precision care for everyone.
  • Expediting interoperability and streamlining, DrAid Enterprise Data Solution (EDS) is hoped to lead the healthcare transformation towards precision care.
  • Dr. Michael C. Muelly, medical partner of VinBrain shared his point of view about clinical practices and values of the solutions during product launch at RSNA 2023.
  • At RSNA 2023, VinBrain also showcased its commitment to providing accessible healthcare in underserved regions with high tuberculosis burden through DrAid for Tuberculosis Screening (CXR Screening).

Study Finds Opto-Acoustic Imaging Provides Significant Cost Benefits When Compared to Ultrasound Alone in Evaluation of Breast Lesions

Retrieved on: 
Thursday, November 30, 2023

San Antonio, TX, Nov. 30, 2023 (GLOBE NEWSWIRE) -- A study presented at RSNA and published in Academic Radiology has found that Seno Medical’s Imagio® Breast Imaging System with opto-acoustic ultrasound (OA/US) imaging is more cost effective when compared to ultrasound alone in evaluating suspicious breast lesions.

Key Points: 
  • San Antonio, TX, Nov. 30, 2023 (GLOBE NEWSWIRE) -- A study presented at RSNA and published in Academic Radiology has found that Seno Medical’s Imagio® Breast Imaging System with opto-acoustic ultrasound (OA/US) imaging is more cost effective when compared to ultrasound alone in evaluating suspicious breast lesions.
  • Imagio’s® non-invasive opto-acoustic ultrasound (OA/US) technology provides functional real-time information about suspicious breast lesions, helping physicians characterize and differentiate masses that may — or may not — require more invasive diagnostic evaluation.
  • Imagio® OA/US technology combines laser optics and grayscale ultrasound to offer fused functional and anatomical breast imaging.
  • The opto-acoustic images provide a unique blood map in and around breast masses, while the ultrasound provides a traditional anatomical image.

Research from Philips and Vanderbilt shows how decarbonizing healthcare also helps to reduce cost

Retrieved on: 
Wednesday, November 29, 2023

The project, which was initially announced in May 2023, shows that sustainable initiatives can be both environmentally friendly and cost-effective.

Key Points: 
  • The project, which was initially announced in May 2023, shows that sustainable initiatives can be both environmentally friendly and cost-effective.
  • In addition, the energy use of scanners accounted for more than half of the total emissions released from diagnostic radiology.
  • The assessment showed that both technology and healthcare practitioners play a significant role in reducing overall greenhouse gas emissions.
  • With sustainability embedded in everything the company does, Philips is leading the way in innovation to enable healthcare that is connected, inclusive, accessible and sustainable.

iCAD’s AI-powered solutions to Help Accelerate Breast Cancer Detection in New Collaboration with GE Healthcare

Retrieved on: 
Tuesday, November 28, 2023

As breast cancer becomes the most commonly diagnosed cancer worldwide, iCAD’s AI solutions are integral to addressing critical issues in breast imaging - such as access, burnout, variability, equity, and cost.

Key Points: 
  • As breast cancer becomes the most commonly diagnosed cancer worldwide, iCAD’s AI solutions are integral to addressing critical issues in breast imaging - such as access, burnout, variability, equity, and cost.
  • GE HealthCare’s MyBreastAI Suite, with iCAD's three key AI-enabled solutions from iCAD, aims to streamline workflow and help clinicians in accelerating breast cancer detection and delivering more personalized and effective breast care.
  • Providing Lesion Scores and Case Scores, ProFound Detection aids in clinical decision-making, workload prioritization, and could help reduce burnout.
  • "Key AI-powered solutions from iCAD’s ProFound Breast Health Suite are the first applications to be integrated with GE HealthCare’s MyBreastAI Suite which is an exciting way to advance our ongoing collaboration to continue deliver breast cancer detection and diagnostic innovation," continued Brown.